Patrice D. Cani chercheur belge
Cani, Patrice D.
Cani, Patrice
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
VIAF ID: 9150686495812541147 (Personal)
Permalink: http://viaf.org/viaf/9150686495812541147
Preferred Forms
-
200 _ | ‡a Cani ‡b Patrice D.
-
100 1 _
‡a
Cani, Patrice
-
100 1 _ ‡a Cani, Patrice D.
-
100 1 _
‡a
Cani, Patrice D.
-
100 1 _
‡a
Cani, Patrice D.
-
100 1 _ ‡a Cani, Patrice D.
-
100 0 _
‡a
Patrice D. Cani
‡c
chercheur belge
4xx's: Alternate Name Forms (8)
5xx's: Related Names (2)
Works
| Title | Sources |
|---|---|
| Assessement of intestinal permeability in human obesity. |
|
| Bugs as drugs, ©2018: |
|
| Bugs as drugs : therapeutic microbes for the prevention and treatment of disease |
|
| Détection portale des nutriments et contrôle de l'homéostasie énergétique par l'axe nerveux intestin-cerveau |
|
| Etude de la perméabilité intestinale au cours de l'obésité humaine |
|
| Impact of a Powdered Meal Replacement on Metabolism and Gut Microbiota (PREMIUM) in individuals with excessive body weight: a study protocol for a randomised controlled trial |
|
| Implication du microbiote intestinal dans l'insulino-résistance et les pathologies hépatiques associées à l'obésité, étude sur modèle murin |
|
| Involvement of gut microbiota in diet-induced insulin resistance and Non Alcoholic Fatty Liver Disease, study on a mouse model. |
|
| The loss of metabolic control on alcohol drinking in heavy drinking alcohol-dependent subjects |
|
| Mediterranean diet, gut microbiota and health: when age and calories do not add up! |
|
| Metabolic endotoxemia initiates obesity and insulin resistance |
|
| Metabolic Imaging Using Hyperpolarized Pyruvate-Lactate Exchange Assesses Response or Resistance to the EGFR Inhibitor Cetuximab in Patient-Derived HNSCC Xenografts |
|
| Metabolism: Dietary emulsifiers--sweepers of the gut lining? |
|
| Metabolite profiling reveals the interaction of chitin-glucan with the gut microbiota |
|
| Microbial Impact on Host Metabolism: Opportunities for Novel Treatments of Nutritional Disorders? |
|
| Microbial modulation of energy availability in the colon regulates intestinal transit |
|
| Microbial signatures in metabolic tissues: a novel paradigm for obesity and diabetes? |
|
| Modulation nutritionnelle de la flore intestinale : une nouvelle approche diététique dans la prise en charge de l’obésité ? |
|
| Monitoring Combretastatin A4-induced tumor hypoxia and hemodynamic changes using endogenous MR contrast and DCE-MRI |
|
| Mucus barrier, mucins and gut microbiota: the expected slimy partners? |
|
| Multi-compartment metabolomics and metagenomics reveal major hepatic and intestinal disturbances in cancer cachectic mice |
|
| N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis |
|
| Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphila |
|
| Non Digestible Oligosaccharides Modulate the Gut Microbiota to Control the Development of Leukemia and Associated Cachexia in Mice. |
|
| Noninvasive monitoring of fibre fermentation in healthy volunteers by analyzing breath volatile metabolites: lessons from the FiberTAG intervention study |
|
| Novel insight into the role of microbiota in colorectal surgery. |
|
| Novel insights into the genetically obese (ob/ob) and diabetic (db/db) mice: two sides of the same coin |
|
| Novel opportunities for next-generation probiotics targeting metabolic syndrome. |
|
| Novel strategy for oral peptide delivery in incretin-based diabetes treatment |
|
| Nutritional depletion inn-3 PUFA in apoE knock-out mice: A new model of endothelial dysfunction associated with fatty liver disease |
|
| Obesity and triple-negative-breast-cancer: Is apelin a new key target? |
|
| Obesity is associated with changes in oxysterol metabolism and levels in mice liver, hypothalamus, adipose tissue and plasma |
|
| Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1. |
|
| [Optimization and safety assessment of Akkermansia muciniphila for human administration]. |
|
| Oral vancomycin treatment does not alter markers of postprandial inflammation in lean and obese subjects |
|
| Pancreatic alpha-cell dysfunction in diabetes |
|
| Peroxisome proliferator-activated receptor-alpha-null mice have increased white adipose tissue glucose utilization, GLUT4, and fat mass: Role in liver and brain |
|
| Physiological effects of dietary fructans extracted from Agave tequilana Gto. and Dasylirion spp. |
|
| Polyphenol-rich extract of pomegranate peel alleviates tissue inflammation and hypercholesterolaemia in high-fat diet-induced obese mice: potential implication of the gut microbiota |
|
| Portal detection of nutrients and control of energy homeostasis by the gut-brain neural axis. |
|
| Positive interaction between prebiotics and thiazolidinedione treatment on adiposity in diet-induced obese mice |
|
| Potential modulation of plasma ghrelin and glucagon-like peptide-1 by anorexigenic cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide |
|
| Prebiotic approach alleviates hepatic steatosis: implication of fatty acid oxidative and cholesterol synthesis pathways |
|
| Prebiotic effects: metabolic and health benefits |
|
| Prebiotics Supplementation Impact on the Reinforcing and Motivational Aspect of Feeding. |
|
| Prebiotics: why definitions matter |
|
| Probiotics, prebiotics, and the host microbiome: the science of translation |
|
| Reduced obesity, diabetes and steatosis upon cinnamon and grape pomace are associated with changes in gut microbiota and markers of gut barrier. |
|
| Régulation de l'expression et de la sécrétion du Peptide YY par des produits du microbiote intestinal dans des cellules entéroendocrines humaines de type L |
|
| Relation between colonic proglucagon expression and metabolic response to oligofructose in high fat diet-fed mice |
|
| Reply |
|
| Reply to 'Simpson's paradox in proof-of-concept studies' |
|
| Restoring specific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model |
|
| Rhubarb Supplementation Prevents Diet-Induced Obesity and Diabetes in Association with Increased Akkermansia muciniphila in Mice |
|
| Ripened dairy products differentially affect hepatic lipid content and adipose tissue oxidative stress markers in obese and type 2 diabetic mice. |
|
| Rôle du macrophage dans les étapes précoces de la stéatohépatite non alcoolique (NASH) |
|
| Role of central nervous system glucagon-like Peptide-1 receptors in enteric glucose sensing |
|
| Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding |
|
| Role of intestinal permeability and inflammation in the biological and behavioral control of alcohol-dependent subjects |
|
| The role of the gut microbiota in energy metabolism and metabolic disease |
|
| Roux-en-Y gastric bypass surgery in rats alters gut microbiota profile along the intestine |
|
| Saccharomyces boulardii administration changes gut microbiota and reduces hepatic steatosis, low-grade inflammation, and fat mass in obese and type 2 diabetic db/db mice |
|
| Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. |
|
| Serum metabolite profiling yields insights into health promoting effect of A. muciniphila in human volunteers with a metabolic syndrome |
|
| Severe obesity and gut microbiota: does bariatric surgery really reset the system? |
|
| Size Effect on Lipid Nanocapsule-Mediated GLP-1 Secretion from Enteroendocrine L Cells. |
|
| Spirulina Protects against Hepatic Inflammation in Aging: An Effect Related to the Modulation of the Gut Microbiota? |
|
| SREBP-1 regulates the expression of heme oxygenase 1 and the phosphatidylinositol-3 kinase regulatory subunit p55 gamma |
|
| Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study |
|
| Synbiotic approach restores intestinal homeostasis and prolongs survival in leukaemic mice with cachexia |
|
| Talking microbes: When gut bacteria interact with diet and host organs |
|
| Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes |
|
| Targeted nanoparticles with novel non-peptidic ligands for oral delivery |
|
| Targeting Carbohydrates and Polyphenols for a Healthy Microbiome and Healthy Weight |
|
| Targeting gut microbiota in obesity: effects of prebiotics and probiotics |
|
| Targeting gut microbiota with a complex mix of dietary fibers improves metabolic diseases |
|
| Targeting the Enteric Nervous System to Treat Metabolic Disorders? "Enterosynes" as Therapeutic Gut Factors |
|
| Targeting the gut microbiota with inulin-type fructans: preclinical demonstration of a novel approach in the management of endothelial dysfunction. |
|
| Tetrahydro iso-alpha acids from hops improve glucose homeostasis and reduce body weight gain and metabolic endotoxemia in high-fat diet-fed mice |
|
| Toll-like receptor 4 knockout mice are protected against endoplasmic reticulum stress induced by a high-fat diet |
|
| Towards a more comprehensive concept for prebiotics |
|
| Toxicological safety evaluation of pasteurized Akkermansia muciniphila |
|
| Transfer of dysbiotic gut microbiota has beneficial effects on host liver metabolism |
|
| The Transplantation of ω3 PUFA-Altered Gut Microbiota of fat-1 Mice to Wild-Type Littermates Prevents Obesity and Associated Metabolic Disorders |
|
| Wheat-derived arabinoxylan oligosaccharides with prebiotic effect increase satietogenic gut peptides and reduce metabolic endotoxemia in diet-induced obese mice. |
|
| When specific gut microbes reveal a possible link between hepatic steatosis and adipose tissue |
|
| প্রত্যুত্তর |
|
